Changing epidemiology of group A streptococcal infection in the USA

The Lancet

Volumn 336, Issue 8724, 1990, Pages 1167-1171

  Schwartz, B ^a   Facklam, R J ^a   Breiman, R F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; UNITED STATES;

ADULT; BIAS (EPIDEMIOLOGY); CHILD; COMPARATIVE STUDY; EVALUATION STUDIES; HUMAN; INCIDENCE; REGRESSION ANALYSIS; SEROTYPING; SPACE-TIME CLUSTERING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES;

EID: 0025084696     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)92777-F     Document Type: Article

References (28)

1. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States
2. Streptococcal outbreaks and erythrogenic toxin type A
3. Epidemiology of group A streptococcal infections—their changing frequency and severity
4. The rise and fall of rheumatic fever
5. Acute rheumatic fever in western Pennsylvania and the tristate area
6. Outbreak of acute rheumatic fever in northeast Ohio
7. Rersurgence of acute rheumatic fever in the intermountain area of the United States
8. Acute rheumatic fever among army trainees, Fort Leonard Wood, Missouri, 1987-1988
9. The return of acute rheumatic fever in young adults
10. Clinical and bacteriologic observations of a toxic shock-like syndrome due to streptococcus pyogenes
11. Toxic strep syndrome
12. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
13. Group A beta-hemolytic streptococcal bacteremia—Colorado, 1989
14. Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated
15. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the Mid-1980s
16. Septic scarlet fever due to Streptococcus pyogenes cellulitis
17. Fatal streptococcal septicaemia
18. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever
19. Changes in the pattern of infection caused by Streptococcus pyogenes
20. Streptococcal M protein: molecular design and biological behaviour
21. Return of rheumatic fever consequences implications and needs
22. Evidence for two distinct classes of M protein and their relationship to rheumatic fever
23. Persistence of type-specific antibodies in man following infection with group A streptococci
24. Type-specific immunity and pharyngeal acquisition of group A streptococcus
25. Controlled studies of streptococcal pharyngitis in a pediatric population
26. Studies on immunity to streptococcal infections in man
27. Type specific serological epidemiology of group-A streptococcal infection